Fielmann AG: Preliminary results of Fielmann AG as at 30 June 2021
|
DGAP-Ad-hoc: Fielmann AG / Key word(s): Half Year Results
HY1 2021 sales increased by +29%, profit surged by approximately +150%
Accelerated by declining coronavirus incidences, the success of vaccination programs and investments in the digitisation and internationalisation of the business, the Fielmann Group's recovery gained pace in Q2 2021 across all major markets. Our sales and profits grew by double digits over last year. HY1 2021 (preliminary results) External sales, including VAT and changes in inventories, increased by +29% to € 919 million (previous year: € 712.7 million). Group sales rose +29% to € 790 million (previous year: € 610.8 million). We expect profit before taxes (EBT) to have risen by approximately +150% to around € 95 million (previous year: € 37.5 million). Outlook Based on the swift recovery during the course of the first half of 2021, we expect for the full year external sales of about €1.9 billion (previous year: €1.6 billion), group sales of circa €1.7 billion (previous year: €1.4 billion) and a pre-tax profit of around €200 million (previous year: €175.5 million). This prognosis is contingent on the assumption that no major, coronavirus-related restrictions will impact our business during the course of the year
08-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fielmann AG |
| Weidetrasse 118a | |
| 22083 Hamburg | |
| Germany | |
| Phone: | +49 (0)40 270 76-0 |
| Fax: | +49 (0)40 270 76-390 |
| Internet: | www.fielmann.de |
| ISIN: | DE0005772206 |
| WKN: | 577220 |
| Indices: | SDAX |
| Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange |
| EQS News ID: | 1216483 |
| End of Announcement | DGAP News Service |
|
|
1216483 08-Jul-2021 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.